Prolonged release oxycodone–naloxone for treatment of severe restless legs syndrome after failure of previous treatment: a double-blind, randomised, placebo-controlled trial with an open-label extension

Claudia Trenkwalder, Ralf Kohnen, Ludger Grote et al.|The Lancet Neurology|2013

Cited by 227